Projects
Using ‘real-world’ data to gain knowledge on medication safety during pregnancy: towards a ‘fit-for-purpose’ registration system on maternal medication use and mother-infant outcomes (BELpREG). KU Leuven
Advanced analytics in pharmaceutical innovation: the use of real world evidence in oncology Vlerick Business School
Coordinating Research and Evidence for Medical Devices KU Leuven
ORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review ...
Evidence Based Simulation Education and Lifelong Learning through ICT 2.0 HOGENT
SRP-Groeifinanciering: Multilingual language control Vrije Universiteit Brussel
Balancing Innovation With Optimization in Oncology: Avenues for Bridging the Cancer Clinical Research Gap KU Leuven
Cancer is an umbrella term referring to a group of debilitating and potentially fatal diseases characterized by the uncontrolled growth and eventual spread of cells that have undergone genetic mutations. Together, these diseases pose an enormous burden on healthcare systems worldwide, killing millions of people each year, and costing the global economy close to a trillion dollars annually. There are various therapeutic modalities available to ...
Using ‘real world’ data to enhance medication safety during pregnancy: towards a ‘fit-for-purpose’ registration system on maternal medication use and mother-infant outcomes (BELpREG) KU Leuven
Evidence on medication safety in pregnancy is lacking for most products, despite their frequent use. As randomized controlled trials cannot be performed in this population, opportunities of ‘real-world’ data collection for pharmacoepidemiologic research should be fully exploited. In 2021, a prototype of a comprehensive registration system on maternal medication use and mother-infant outcomes (BELpREG) was developed at KU Leuven, allowing data ...
Pharmacodynamics models to bridge the gap between exposure and response to antimicrobial treatments KU Leuven
Identification of patient-specific parameters for bolus calculators in type 1 diabetic patients KU Leuven
In type 1 diabetes (T1D) the individual’s immune system attacks the insulin producing beta cells of the pancreas and destroys them. Therefore, people with T1D need exogenous insulin to survive, however, achieving optimal glycaemic control while avoiding hypoglycaemia remains a challenge despite rapid advancements in insulin administration technology and better insulin preparations. To inject the right dose of insulin, it is essential that the ...